drugset
drugset / Trial / NCT06708416

A Study of ONO-1110 in Patients With Postherpetic Neuralgia

NCT06708416 ↗

Phase 2 Completed 142 enrolled Ono Pharmaceutical Co., Ltd.
RandomizedParallel-groupDouble-blindTreatment

Summary

To evaluate the efficacy and safety of ONO-1110 in Japanese patients with postherpetic neuralgia

Timeline

Start
2025-02-12
Primary completion
2026-05-11
Completion
2026-05-11

Drugs

EvaluationDrugModalityDoseRoute
Subject ONO-1110 Unknown — —

Indications

postherpetic neuralgia